What’s New?

The April 2016 website update includes the following changes and additions.  Thank you for visiting the ECDGA webpage!

  • Six new Studies & Trials have been announced at MD Anderson in Houston, TX.  Also, the NIH Phase 2 Therapeutic Trial of the Use of Dabrafenib and Trametinib was updated with links and additional information.
  • Three new Care Centers were announced since the last update.  A new US center is located in Missouri.  International additions include Lebanon and Brazil.
  • Press Releases highlighting the new ECD Care Centers, fundraisers and Rare Disease Day activities and proclamations are available.
  • New fundraiser success and examples from the recent Rare Disease Day events are included on Host Fundraisers.
  • Two journal articles written about ECD have become available online.  View 2016 additions, Detection of an NRAS mutation in Erdheim-Chester disease and  Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease, in Medical Journal Articles.
  • Updated the contact information for Ophthalmologist Kleanthis Manousaridis, MD PhD in Knowledgeable Doctors.
  • An ECD Awareness Week page has been created to help the community learn more about this special occasion and how to make this year’s event simple and effective.

Contact Us

  • ECD Global Alliance, P.O. Box 775,
    DeRidder, LA 70634 USA

Featured Partners

Copyright 2024. All rights Reserved ECD GLOBAL ALLIANCE. A 501(c)(3) organization. EIN# 27-0759192. | Privacy Policy